U.S. Markets closed

Daily Digit: Novartis raises outlook

Swiss drug maker Novartis raises its full-year outlook for a second consecutive quarter, due to the ongoing absence of generic competition to its best-selling blood pressure pill, Diovan. Hayley Platt reports.